Vendor, Denver, CO
Denver Health and Hospital Authority
UEI MMT4LGM4H9Z5, CAGE 1RS53
4 awards and $1,298,447 obligated between June 24, 2026 and August 23, 2026, 100% under full and open competition, against 9.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Centers for Disease Control and Prevention | $1,298,447 |
| Food and Drug Administration | $0 |
Industries
NAICS on the awards, by dollars.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 4 |
| Delivery Order | 3 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30126F00002Delivery Order, August 23, 2026, Full and Open Competition, 12 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Evaluating the Childhood Vaccination Schedule Eo 14398NAICS 541990, PSC R499 | $1,208,092 |
| 75D30121C10166Definitive Contract, June 30, 2026, Full and Open Competition, 22 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Tuberculosis Trials and Consortium ServicesNAICS 541714, PSC AN12 | $90,355 |
| 75F40121F19001Delivery Order, July 8, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Data Resources for Post-Marketing Surveillance of Nonmedical Use of Pharmaceuticals and Use of Illicit Drug SubstancesNAICS 541715, PSC B529 | $0 |
| 75F40122F19002Delivery Order, June 24, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Understanding the Prevalence, Experiences, Knowledge, and Perceptions of Falsified and Unapproved Pharmaceuticals in a General Population ReNAICS 541715, PSC B529 | $0 |
- Product and service codes
- R499 Other Professional ServicesAN12 Health R&D Services; Health Care Services; Applied ResearchB529 Scientific Data Studies
- Transactions
- 5 across 4 awards